Meeting
2023 ASCO Genitourinary Cancers Symposium
Therapeutic potential of plant-derived nanovesicles for neuroendocrine prostate cancer.
Authors
Sharanjot Saini
Augusta University, Augusta, GA
Sharanjot Saini , Amritha Sreekumar , Tae Jin Lee , Ashok Sharma , Matthew Simmons
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 186)
DOI
10.1200/JCO.2023.41.6_suppl.186
Abstract #
186
Poster Bd #
F1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Lipidomic profiling as a biomarker for prostate cancer diagnosis and response to enzalutamide (Enza).
First Author: Sara Bleve
Poster
2024 ASCO Genitourinary Cancers Symposium
A phase 1/2 study of ONCT-534, a dual-action androgen receptor inhibitor (DAARI), in patients with metastatic castration-resistant prostate cancer.
First Author: Evan Y. Yu
Poster
2024 ASCO Genitourinary Cancers Symposium
ERBB3 expression in racially diverse patients with castration-sensitive prostate cancer and its association with a unique AR activity signature.
First Author: Jordan Vellky
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of emergent neuroendocrine prostate cancer detected by liquid biopsies with survival and treatment resistance.
First Author: Amy K Taylor